Raffles Medical Group Ltd carries a market capitalization of 1.69B, placing it among publicly traded companies globally. Its enterprise value stands at 1.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.69B |
| Enterprise Value | 1.87B |
Raffles Medical Group Ltd currently has 1.83B shares outstanding.
| Shares Outstanding | 1.83B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Raffles Medical Group Ltd trades at a trailing price-to-earnings ratio of 30.00. The price-to-sales ratio is 3.46, and the price-to-book ratio stands at 4.60.
| PE Ratio | 30.00 |
| PS Ratio | 3.46 |
| PB Ratio | 4.60 |
| P/TBV Ratio | 2.21 |
| P/FCF Ratio | 8.69 |
| P/OCF Ratio | 16.44 |
On an enterprise value basis, Raffles Medical Group Ltd trades at an EV/EBITDA multiple of 23.93 and an EV/FCF ratio of 8.92. The EV/Sales ratio of 3.59 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.93 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.59 |
| EV / EBITDA | 23.93 |
| EV / EBIT | 23.93 |
| EV / FCF | 8.92 |
Raffles Medical Group Ltd maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.39, indicating elevated leverage, while an interest coverage ratio of 40.32 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.12 |
| Quick Ratio | 0.69 |
| Debt / Equity | 23.39 |
| Debt / EBITDA | 2.56 |
| Interest Coverage | 40.32 |
Raffles Medical Group Ltd posts a return on equity of 15.89 and a return on invested capital of 6.18.
| Return on Equity (ROE) | 15.89 |
| Return on Assets (ROA) | 5.02 |
| Return on Invested Capital (ROIC) | 6.18 |
| Return on Capital Employed (ROCE) | 11.12 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 11.34 |
Over the trailing twelve months, Raffles Medical Group Ltd has paid 15.40M in income taxes, reflecting an effective tax rate of 20.29.
| Income Tax | 15.40M |
| Effective Tax Rate | 20.29 |
Raffles Medical Group Ltd's stock has declined approximately -8% over the past 52 weeks. The 50-day moving average sits at 0.96, while the 200-day moving average is 0.99.
| Beta (5Y) | N/A |
| 52-Week Price Change | -8% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 0.99 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Raffles Medical Group Ltd generated 522.04M in revenue and converted that into 60.27M in net income, yielding earnings per share of 0.03. EBITDA reached 78.25M, while operating income came in at 78.25M.
| Revenue | 522.04M |
| Gross Profit | 411.07M |
| Operating Income | 78.25M |
| Pretax Income | 75.92M |
| Net Income | 60.27M |
| EBITDA | 78.25M |
| EBIT | 78.25M |
| Earnings Per Share (EPS) | 0.03 |
Raffles Medical Group Ltd holds 151.83M in cash and equivalents against 200.38M in total debt, resulting in a net debt position of 13.28M. Total book value stands at 393.47M, with working capital of 27.05M providing operational flexibility.
| Cash & Cash Equivalents | 151.83M |
| Total Debt | 200.38M |
| Net Debt | 13.28M |
| Equity (Book Value) | 393.47M |
| Book Value Per Share | 0.22 |
| Working Capital | 27.05M |
Raffles Medical Group Ltd produced 110.02M in operating cash flow over the past twelve months. After subtracting -98.38M in capital expenditures, free cash flow totaled 11.64M - equivalent to 0.01 per share.
| Operating Cash Flow | 110.02M |
| Capital Expenditures | -98.38M |
| Free Cash Flow | 11.64M |
| FCF Per Share | 0.01 |
Raffles Medical Group Ltd operates with a gross margin of 78.74, reflecting its pricing power and cost economics. The operating margin of 14.99 and net profit margin of 11.55 provide insight into operational efficiency.
| Gross Margin | 78.74 |
| Operating Margin | 14.99 |
| Pretax Margin | 14.54 |
| Profit Margin | 11.55 |
| EBITDA Margin | 14.99 |
The company's payout ratio of 29.54 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | 29.54 |
| Shareholder Yield | -1.81 |
| FCF Yield | 11.51 |
Raffles Medical Group Ltd's most recent stock split took place on May 9, 2016 with a 1:3 split ratio.
| Last Split Date | 5/9/2016 |
| Split Ratio | 1:3 |
Raffles Medical Group Ltd posts an Altman Z-Score of 3.19, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.19 |